Skip to main content

What the FDA labels say about taking them together

Quetiapine and rifampin

Quetiapine's FDA label of April 10, 2026 names rifampin in its drug interactions section; the rifampin label PlainMeds reads does not name quetiapine. The quetiapine label: “Concomitant use of strong CYP3A4 inducers: Increase quetiapine dose up to 5 fold when used in combination with a chronic treatment (more than 7-14 days) of potent CYP3A4 inducers”

Check it at the source: the quetiapine FDA label on DailyMed (effective April 10, 2026, H2-Pharma, LLC); the rifampin FDA label on DailyMed (effective February 11, 2026, Lupin Pharmaceuticals, Inc.).

What does the quetiapine label say about rifampin?

Quetiapine label, drug interactions

Concomitant use of strong CYP3A4 inducers: Increase quetiapine dose up to 5 fold when used in combination with a chronic treatment (more than 7-14 days) of potent CYP3A4 inducers (e.g., phenytoin, rifampin, St. John’s wort)

Source: FDA drug label (SEROQUEL), NDA020639 (Cheplapharm), as published by H2-Pharma, LLC, effective April 10, 2026 (SPL set 8ae62aaf-f8c5-417f-baac-0098369ca322), via openFDA; the full label on DailyMed

What does the rifampin label say about quetiapine?

Rifampin's label (effective February 11, 2026) does not name quetiapine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (rifampin), Lupin Pharmaceuticals, Inc., effective February 11, 2026 (SPL set b56004f0-f23d-47f6-80c7-39884fccbccc), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

48Quetiapine generic labelers
13Rifampin generic labelers
QuetiapineRifampin
Labeled forSchizophrenia, Bipolar disorder, Depressionn/a
Boxed warningYesNo
Pharmacy cost (NADAC)$0.127 per tablet 300 mg tablet$0.679 per capsule 300 mg capsule
Shortage nowNo current entryIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?